We have 5 of 32 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Schiff base structures have been identified as potential multi-functional platforms for the development of novel agents for neuroprotection against the effects of motor impairment and non-motor dysfunction in PD patients.
This study investigates the concepts that underpin the integration of AMPs with nanofibers, such as electrospinning processes, encapsulating strategies, and controlled release mechanisms, as well as their potential to combat microbial resistance.
Reviewing Epidermal Growth Factor Receptor (EGFR) T790M and BCR::ABL1 T315I mutations reveals that the important interactions and binding sites are removed or obstructed with the drug.
Overall, chalcone-based MTDLs provide a rational framework for the development of next-generation anti-Alzheimer agents, highlighting the effects of hydroxylation, methoxylation, halogenation, halogenation, and heterocyclic hybridization on biological activity.
This research highlights the feasibility of using thiazole-derived AChE, BuChE, MAO-B, and amyloid-β inhibitors as scaffold pharmacophores for developing novel drugs to treat Alzheimer's disease and provides vital guidance on the development of future drugs.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
